Xeris 生物製藥控股公司
| Security | XERS / Xeris Biopharma Holdings, Inc. |
| Insider | John Johnson |
This page shows the track record and history of JOHNSON JOHN
insider trades in Xeris Biopharma Holdings, Inc.. The SEC defines Insiders as officers, directors, or significant investors (greater than 10% ownership) in a company.
It is illegal for insiders to make trades in their companies based on material, non-public information ("MNPI"). This does not mean
it is illegal for them to make any
trades in their own companies. However, they must report all trades to the SEC via a Form 4.
Insider Purchases - Short Term Profit Analysis
In this section, we analyze the profitability of every unplanned, open-market insider purchase made by John Johnson in XERS / Xeris Biopharma Holdings, Inc.. This analysis helps to understand if the insider consistently generates abnormal returns, and is worth following. This analysis is for one-year following each trade, and the results are theoretical.
The following table shows the most recent open market purchases that were not part of an automatic trading plan.
| Trade Date | Reported Shares |
Reported Price |
Adjusted Shares |
Adjusted Price |
Cost Basis | Days to Max |
Price at Max |
Max Profit ($) |
Max Return (%) |
|---|---|---|---|---|---|---|---|
| There are no known unplanned open-market trades for this insider |
Adjusted Price is the split-adjusted price. Adjusted Shares is the split-adjusted shares.
Insider Sales - Short Term Loss Analysis
In this section, we analyze the short-term loss avoidance of every unplanned, open-market insider sale made by John Johnson in XERS / Xeris Biopharma Holdings, Inc.. A consistent pattern of loss avoidance may suggest that future sale transactions may predict declines in price. This analysis is for one-year following each trade, and the results are theoretical.
The following table shows the most recent open market purchases that were not part of an automatic trading plan.
Adjusted Price is the split-adjusted price. Adjusted Shares is the split-adjusted shares.
Insider Transaction History
| File Date |
Trade Date |
Form | Insider | Ticker | Security Title | Code | Direct | Exercise Price |
Unit Price |
Units Changed |
Value Changed (1K) |
Remaining Options |
Remaining Shares |
|
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026-06-05 | 2026-06-04 | 4 | JOHNSON JOHN | XERS | Common Stock | D | 24,193 | 707,276 | ||||||
| 2026-06-05 | 2026-06-04 | 4 | JOHNSON JOHN | XERS | Common Stock | D | 6.0948 | -15,000 | -91 | 683,083 | ||||
| 2025-12-19 | 2025-12-19 | 4 | JOHNSON JOHN | XERS | Common Stock | D | 7.2158 | -135,400 | -977 | 698,083 | ||||
| 2025-08-15 | 2025-08-13 | 4 | JOHNSON JOHN | XERS | Common Stock | D | 7.3159 | -107,500 | -786 | 833,483 | ||||
| 2025-06-04 | 2025-06-04 | 4 | JOHNSON JOHN | XERS | Common Stock | D | 50,000 | 940,983 | ||||||
| 2024-06-05 | 2024-06-05 | 4 | JOHNSON JOHN | XERS | Common Stock | D | 50,000 | 890,983 | ||||||
| 2024-04-01 | 2024-03-15 | 4 | JOHNSON JOHN | XERS | Common Stock | D | 89,571 | 840,983 | ||||||
| 2024-03-18 | 2024-03-18 | 4 | JOHNSON JOHN | XERS | Common Stock | D | 1.9900 | 215,600 | 429 | 751,412 | ||||
| 2023-06-07 | 2023-06-07 | 4 | JOHNSON JOHN | XERS | Common Stock | D | 42,500 | 535,812 | ||||||
| 2022-06-09 | 2022-06-08 | 4 | JOHNSON JOHN | XERS | Common Stock | D | 15,000 | 493,312 | ||||||
| 2021-10-08 | 2021-10-05 | 4/A | JOHNSON JOHN | XERS | Stock Option (Right to Buy) | D | 2.37 | 2.3700 | 19,650 | 47 | 19,650 | |||
| 2021-10-08 | 2021-10-05 | 4/A | JOHNSON JOHN | XERS | Stock Option (Right to Buy) | D | 2.43 | 68,600 | 68,600 | |||||
| 2021-10-08 | 2021-10-05 | 4/A | JOHNSON JOHN | XERS | Stock Option (Right to Buy) | D | 1.99 | 215,600 | 215,600 | |||||
| 2021-10-08 | 2021-10-05 | 4/A | JOHNSON JOHN | XERS | Stock Option (Right to Buy) | D | 7.02 | 31,360 | 31,360 | |||||
| 2021-10-08 | 2021-10-05 | 4/A | JOHNSON JOHN | XERS | Stock Option (Right to Buy) | D | 9.89 | 31,360 | 31,360 | |||||
| 2021-10-08 | 2021-10-05 | 4/A | JOHNSON JOHN | XERS | Stock Option (Right to Buy) | D | 5.62 | 31,360 | 31,360 | |||||
| 2021-10-08 | 2021-10-05 | 4/A | JOHNSON JOHN | XERS | Stock Option (Right to Buy) | D | 22.39 | 10,367 | 10,367 | |||||
| 2021-10-08 | 2021-10-05 | 4/A | JOHNSON JOHN | XERS | Common Stock | D | 478,312 | 478,312 | ||||||
| 2021-10-05 | 2021-10-05 | 4 | JOHNSON JOHN | XERS | Stock Option (Right to Buy) | D | 2.43 | 68,600 | 68,600 | |||||
| 2021-10-05 | 2021-10-05 | 4 | JOHNSON JOHN | XERS | Stock Option (Right to Buy) | D | 1.99 | 215,600 | 215,600 | |||||
| 2021-10-05 | 2021-10-05 | 4 | JOHNSON JOHN | XERS | Stock Option (Right to Buy) | D | 7.02 | 31,360 | 31,360 | |||||
| 2021-10-05 | 2021-10-05 | 4 | JOHNSON JOHN | XERS | Stock Option (Right to Buy) | D | 9.89 | 31,360 | 31,360 | |||||
| 2021-10-05 | 2021-10-05 | 4 | JOHNSON JOHN | XERS | Stock Option (Right to Buy) | D | 5.62 | 31,360 | 31,360 | |||||
| 2021-10-05 | 2021-10-05 | 4 | JOHNSON JOHN | XERS | Stock Option (Right to Buy) | D | 22.39 | 10,367 | 10,367 | |||||
| 2021-10-05 | 2021-10-05 | 4 | JOHNSON JOHN | XERS | Common Stock | D | 478,312 | 478,312 |
P
非衍生或衍生證券的公開市場或私下買入
S
非衍生或衍生證券的公開市場或私下賣出
A
公司向內部人員授予、獎勵或以其他方式獲取證券（例如股票期權）
C
衍生工具轉換
D
將證券賣出或轉讓回公司
F
使用從公司收到的證券的一部分來支付行使價或稅務負擔。
G
內部人士贈送或接收他人贈送公司股票
K
股權掉期和類似的避險交易
M
行使或轉換從公司獲得的衍生證券（例如期權）
V
內部人士透過Form 4自願報告的一筆交易
J
其他（附有交易描述的腳註）
